MarketInOut Stock Screener Log In | Sign Up

VolitionRX Ltd

NYSE • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
VolitionRX Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNYSE
Market Capitalization5.56 mln
Float25.19 mln
Earnings Date11/12/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-6.19
Highly reliable

1-Year Forecast

13.62
Transformational upside

Relative Strength

93 / 100
Top performer

Pre-Tax Margin

-1,047%
Severely loss-making

ROE

77.10
Exceptional

Business Description

VolitionRx Limited is a Nevada-based company operating across the United States, Europe, and Asia that develops blood tests to identify and track cancer and other serious illnesses. Its products cover a wide range of needs, from screening animals for cancer to helping doctors monitor how well a patient is responding to treatment. The company also offers tools for studying genetic material in the blood, including methods to isolate cancer-related DNA at an early stage. VolitionRx serves both human and veterinary medicine, making it a broad player in the field of disease detection through blood analysis.

Key Fundamentals

EPS-3.90
ROE77.10
RPS0.36
ROIC-199
ROA-325
Interest Cover-5.93
EBITDA, mln-20.91
EV / EBITDA-0.50
EV / EBIT-0.48
Revenue, mln2.46
EV / Revenue4.29

Quote Details

Last 0.1953
Change -0.0022 (-1.11%)
Open 0.20
Volume 1,060,988
Turnover 207,211
Average Volume 1,114,786

Financial Ratios

Pre-Tax Profit Margin-1,047
Current Ratio0.30
Price / Sales0.68

Financial Strength

Altman Z-Score-54.82
Piotroski F-Score 4 / 9
Beneish M-Score-6.19
1-Year Target Price13.62
Short Ratio0.37
Short % of Float4.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 12.18% 98 / 100   
1 Month -16.79% 8 / 100   
2 Months -77.81% 0 / 100   
6 Months -91.96% 0 / 100   
1 Year -97.73% 0 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog